RxVantage Signs Strategic Agreement with Key Organization for Nation’s Rheumatologists

Partnership to Provide Rheumatologist Members Improved Efficiency Between Office Staff and Medical Reps

RxVantage Signs Strategic Agreement with Key Organization for Nation’s Rheumatologists

<0> Scott Public RelationsBrenna Harrington770-338-0357 </0>

, a healthcare technology company with an innovative cloud-based platform that enables physicians' practices to streamline and improve their relationships with pharmaceutical and other medical sales reps, today announced the company was endorsed by (NORM).

The NORM Board of Directors vetted RxVantage and determined that the free platform would provide significant value to their members by solving a problem members face daily. The RxVantage platform will save NORM practices thousands of hours per year, collectively, by driving efficiency into the process of managing the educational interactions between their doctors and the medical reps that call on them.

“Medical innovations are advancing at an incredible pace across the board, and Rheumatology is no exception,” notes Iris Nichols, President of NORM. “The representatives from the companies who develop breakthrough medications and medical devices strive to provide valuable education for our doctors, staff, and patients. RxVantage enables NORM member practices to recapture time that was previously spent managing these interactions and focus it back on patient care.”

RxVantage’s online scheduling system streamlines the scheduling process for pharmaceutical and other medical sales representatives and saves medical practices an average of 15 hours per month at no cost. Its comprehensive range of efficiency tools for medical offices include the ability to easily request samples and better communicate with medical representatives. RxVantage also offers a patient savings center module with an up-to-date directory of patient assistance programs and a drug coupon database, a feature especially important to rheumatologists.

The NORM endorsement follows several others endorsements of RxVantage from key organizations, including the and the (MOASC), a regional affiliate for the national oncology organization.

In addition, RxVantage has continued its growth and outreach to the provider community through several key acquisitions and mergers, including RxAssist, a company providing online information to providers about Patient Assistance Programs (PAP) and RepAccess, a regional rep scheduling company.

“There is a reason 90% of practice administrators who see a demo adopt RxVantage,” notes Jay Goss, CEO of RxVantage. “Our ongoing growth and strategic agreements with organizations such as NORM highlight the value thousands of physician practices place in ongoing relationships with trusted and proven pharmaceutical reps.”

For more information on RxVantage’s strategic partners, please visit .

RxVantage is a Los Angeles based healthcare technology company with an innovative cloud-based platform that enables physicians' practices to streamline and improve their relationships with pharmaceutical and other medical sales reps. The platform includes a rules-based rep scheduling application and a suite of software tools designed to make requesting samples and communicating with medical reps markedly more efficient. Powered by RxAssist, the technology also features an up-to-date, centralized directory of patient assistance programs and a comprehensive drug coupon database, which greatly simplifies the practices' task of researching prescription medication information on behalf of its patients. For more information, visit or call 866-464-2157.

Suggested Articles

Signify Health, a technology company that supports in-home care announced plans to merge with Remedy Partners, a software company that collaborates with…

There are big changes coming to the pharmacy industry and the traditional industry players will need to innovate and pivot to health and wellness to stay ahead.

An assessment looking at 12 health systems that allow patients to download their health records to their smartphones via APIs finds modest uptake.